Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hematologic Neoplasms × pemigatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Cholangiocarcinoma 2 Solid Tumor, Miscellaneous 1 Recurrence 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Advanced Non Small Cell Lung Cancer 1

Interventions

Cyclophosphamide 21 fludarabine 18 venetoclax 8 Mycophenolic Acid 8 Whole-Body Irradiation 7 fludarabine phosphate 6 Standard of Care 6 Sirolimus 6 Mesna 6 Melphalan 6 Azacitidine 6 Tacrolimus 5 thymoglobulin 4 Thiotepa 4 Specimen Handling 4 Practice Guidelines as Topic 4 Filgrastim 4 Cytarabine 4 Blood Specimen Collection 4 pegylated granulocyte colony-stimulating factor 3 daratumumab 3 cobimetinib 3 Vemurafenib 3 Surveys and Questionnaires 3 Palliative Care 3 Granulocyte Colony-Stimulating Factor 3 Busulfan 3 Bortezomib 3 Behavior Therapy 3 tagraxofusp 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05159245 2024-07-15

FINPROVE

Helsinki University Central Hospital

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡